Exploring environmental modifiers of LRRK2-associated Parkinson's disease penetrance: An exposomics and metagenomics pilot study on household dust

被引:0
|
作者
Andujar, Begona Talavera [1 ]
Pereira, Sandro L. [1 ]
Busi, Susheel Bhanu [1 ,2 ]
Usnich, Tatiana [3 ]
Borsche, Max [3 ,4 ]
Ertan, Sibel [5 ]
Bauer, Peter [6 ]
Rolfs, Arndt [6 ]
Hezzaz, Soraya [1 ]
Ghelfi, Jenny [1 ]
Brueggemann, Norbert [3 ,4 ]
Antony, Paul [1 ]
Wilmes, Paul [1 ,7 ]
Klein, Christine [3 ]
Gruenewald, Anne [1 ]
Schymanski, Emma L. [1 ]
机构
[1] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, L-4367 Belvaux, Luxembourg
[2] UK Ctr Ecol & Hydrol, Wallingford, Oxon, England
[3] Univ Lubeck, Inst Neurogenet, Lubeck, Germany
[4] Univ Lubeck, Dept Neurol, Lubeck, Germany
[5] Koc Univ, Sch Med, Dept Neurol, Istanbul, Turkiye
[6] CENTOGENE GmbH, Rostock, Germany
[7] Univ Luxembourg, Fac Sci Technol & Med, Dept Life Sci & Med, L-4362 Esch Sur Alzette, Luxembourg
关键词
Indoor environment; Exposomics; Metagenomics; Parkinson's disease; Leucine-rich repeat kinase 2 (LRRK2); Bisphenol S; MASS-SPECTROMETRY; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; PIPECOLIC ACID; IN-VITRO; MANAGEMENT; RELEVANCE; FIPRONIL; BACTERIA;
D O I
10.1016/j.envint.2024.109151
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Pathogenic variants in the Leucine-rich repeat kinase 2 (LRRK2) gene are a primary monogenic cause of Parkinson's disease (PD). However, the likelihood of developing PD with inherited LRRK2 pathogenic variants differs (a phenomenon known as "reduced penetrance"), with factors including age and geographic region, highlighting a potential role for lifestyle and environmental factors in disease onset. To investigate this, household dust samples from four different groups of individuals were analyzed using metabolomics/exposomics and metagenomics approaches: PD+/LRRK2+ (PD patients with pathogenic LRRK2 variants; n = 11), PD-/LRRK2+ (individuals with pathogenic LRRK2 variants but without PD diagnosis; n = 8), iPD (PD of unknown cause; n = 11), and a matched, healthy control group (n = 11). The dust was complemented with metabolomics and lipidomics of matched serum samples, where available. A total of 1,003 chemicals and 163 metagenomic operational taxonomic units (mOTUs) were identified in the dust samples, of which ninety chemicals and ten mOTUs were statistically significant (ANOVA p-value < 0.05). Reduced levels of 2-benzothiazolesulfonic acid (BThSO3) were found in the PD-/LRRK2+ group compared to the PD+/LRRK2+ . Among the significant chemicals tentatively identified in dust, two are hazardous chemical replacements: Bisphenol S (BPS), and perfluorobutane sulfonic acid (PFBuS). Furthermore, various lipids were found altered in serum including different lysophosphatidylethanolamines (LPEs), and lysophosphatidylcholines (LPCs), some with higher levels in the PD+/LRRK2+ group compared to the control group. A cellular study on isogenic neurons generated from a PD+/LRRK2+ patient demonstrated that BPS negatively impacts mitochondrial function, which is implicated in PD pathogenesis. This pilot study demonstrates how non-target metabolomics/exposomics analysis of indoor dust samples complemented with metagenomics can prioritize relevant chemicals that may be potential modifiers of LRRK2 penetrance.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations?
    Loeffler, David A.
    Aasly, Jan O.
    LeWitt, Peter A.
    Coffey, Mary P.
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (03) : 467 - 488
  • [32] Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's disease
    Podlesniy, Petar
    Puigros, Margalida
    Serra, Nuria
    Fernandez-Santiago, Ruben
    Ezquerra, Mario
    Tolosa, Eduardo
    Trullas, Ramon
    EBIOMEDICINE, 2019, 48 : 554 - 567
  • [33] Genetic LRRK2 Models of Parkinson's Disease: Dissecting the Pathogenic Pathway and Exploring Clinical Applications
    Yue, Zhenyu
    Lachenmayer, M. Lenard
    MOVEMENT DISORDERS, 2011, 26 (08) : 1386 - 1397
  • [34] Identification of Three Novel LRRK2 Mutations associated with Parkinson's Disease in a Calabrian Population
    Anfossi, Maria
    Colao, Rosanna
    Gallo, Maura
    Bernardi, Livia
    Conidi, M. Elena
    Frangipane, Francesca
    Vasso, Franca
    Puccio, Gianfranco
    Clodomiro, Alessandra
    Mirabelli, Maria
    Curcio, Sabrina A. M.
    Torchia, Giusi
    Smirne, Nicoletta
    Di Lorenzo, Raffaele
    Maletta, Raffaele
    Bruni, Amalia C.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 38 (02) : 351 - 357
  • [35] Psilocybin Therapy for Depression and Anxiety Associated With Parkinson's Disease: A Pilot Study
    Bradley, Ellen
    Sakai, Kim
    Fernandes, Gisele
    Ludwig, Connie
    Bock, Meredith
    Ostrem, Jill
    Tanner, Caroline
    O'Donovan, Aoife
    Finley, Patrick
    Busby, Zach
    McKernan, Amber
    Zuzuarregui, Jose Rafael
    Penn, Andrew
    Wang, Aliss
    Rosen, Ray
    Woolley, Josh
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 296 - 297
  • [36] Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation
    Giordana, Maria Teresa
    D'Agostino, Carla
    Albani, Giovanni
    Mauro, Alessandro
    Di Fonzo, Alessio
    Antonini, Angelo
    Bonifati, Vincenzo
    MOVEMENT DISORDERS, 2007, 22 (02) : 275 - 278
  • [37] Sedentary Time is Associated with Worse Attention in Parkinson's Disease: A Pilot Study
    Troutman, Sara B. W.
    Erickson, Kirk I.
    Grove, George
    Weinstein, Andrea M.
    JOURNAL OF MOVEMENT DISORDERS, 2020, 13 (02) : 146 - 149
  • [38] G2019S Variation in LRRK2: An Idea Model for the Study of Parkinson's Disease?
    Ren, Chao
    Ding, Yu
    Wei, Shizhuang
    Guan, Lina
    Zhang, Caiyi
    Ji, Yongqiang
    Wang, Fen
    Yin, Shaohua
    Yin, Peiyuan
    FRONTIERS IN HUMAN NEUROSCIENCE, 2019, 13
  • [39] Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson's disease: A mechanistic study
    Wang, Yan
    Gao, Pengpeng
    Wu, Zicong
    Jiang, Bing
    Wang, Yanru
    He, Zhaxicao
    Zhao, Bing
    Tian, Xinyun
    Gao, Han
    Cai, Li
    Li, Wentao
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 338
  • [40] LRRK2-NFATc2 Pathway Associated with Neuroinflammation May Be a Potential Therapeutic Target for Parkinson's Disease
    Wang, Youcui
    Zhang, Xiaoqin
    Chen, Fenghua
    Chen, Leilei
    Wang, Jun
    Xie, Junxia
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 2583 - 2586